Skip to main content
. 2021 Jun 17;8:653312. doi: 10.3389/fcvm.2021.653312

Figure 1.

Figure 1

Enhanced plasma soluble suppression of tumorigenicity 2 (sST2) was found in persistent atrial fibrillation (AF) patients. Plasma levels of sST2 were measured by enzyme-linked immunosorbant assay (ELISA) kit and presented by dot plots. PaAF, paroxysmal AF; PeAF, persistent AF. *P < 0.01 vs. PeAF.